Chapman Marcus 4
4 · Seres Therapeutics, Inc. · Filed Apr 24, 2020
Insider Transaction Report
Form 4
Chapman Marcus
See Remarks
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2020-04-22+18,596→ 18,596 totalExercise: $3.74Exp: 2030-04-21→ Common Stock (18,596 underlying)
Footnotes (1)
- [F1]The option will vest in full on April 22, 2021.